Q9UBL3 (ASH2L_HUMAN) Homo sapiens (Human)
Set1/Ash2 histone methyltransferase complex subunit ASH2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
However, an attempt to improve models for this target was made on 2025-04-08. The outcome - failed for technical reasons.
Available Structures
27 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Cryo-EM structure of MLL1 core complex bound to the nucleosome |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; Q9C005; | 100 | 2×SAH; 2×ZN; | |||
| Complex between MLL1-WRAD and an H2B-ubiquitinated nucleosome |
Heteromer B4DIJ7; P02281; P06897; P0CG47; P61964; P62799; P84233; Q15291; Q9C005; | 100 | 1×SAH; 1×ZN; | |||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 100.0 | ||||
| Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode02 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 100 | ||||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 100.0 | ||||
| Cryo-EM structure of MLL1 in complex with RbBP5, WDR5, SET1, and ASH2L bound to the nucleosome (Cla… |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 100.0 | ||||
| Crystal structure of human Ash2L (SPRY domain and SDI motif) in complex with full length DPY-30 |
Heteromer Q9C005; | 100 | ||||
| The crystal structure of MLL1 (N3861I/Q3867L) in complex with RbBP5 and Ash2L |
Heteromer Q03164; Q15291; | 100.0 | 1×SAH; 1×ZN; | |||
| Crystal structure of Ash2L SPRY domain in complex with phosphorylated RbBP5 |
Heteromer Q15291; | 100.0 | ||||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me0 peptide |
Heteromer Q03164; Q15291; Q6NXT2; | 100.0 | 1×SAH; 1×ZN; | |||
| Crystal structure of Ash2L SPRY domain in complex with RbBP5 |
Heteromer Q15291; | 100.0 | 1×GOL; | |||
| Crystal structure of the MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L complex |
Heteromer Q03164; Q15291; | 100.0 | 1×SAH; 1×ZN; | |||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me1 peptide |
Heteromer Q03164; Q15291; Q6NXT2; | 100.0 | 1×SAH; 1×ZN; | |||
| The crystal structure of MLL1 (N3861I/Q3867L/C3882SS)-RBBP5-ASH2L in complex with H3K4me2 peptide |
Heteromer Q03164; Q15291; Q6NXT2; | 100.0 | 1×SAH; 1×ZN; | |||
| The crystal structure of MLL3-RBBP5-ASH2L in complex with H3K4me0 peptide |
Heteromer Q15291; Q6NXT2; Q8NEZ4; | 100.0 | 2×ZN; 2×SAH; | |||
| Crystal structure of the MLL3-Ash2L-RbBP5 complex |
Heteromer Q15291; Q6NXT2; Q8NEZ4; | 100.0 | 2×ZN; 2×SAH; | |||
| The crystal structure of MLL2 in complex with ASH2L and RBBP5 |
Heteromer Q15291; Q9UMN6; | 100.0 | 1×ZN; 1×SAH; | |||
| Cryo-EM structure of MLL1-NCP (H3K4M) complex, mode01 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 100.0 | ||||
| Cryo-EM structure of human MLL1-ubNCP complex (3.2 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q03164; Q15291; | 100.0 | 1×SAH; 1×ZN; 1×LYS; 1×GLN; | |||
| Cryo-EM structure of human MLL1-ubNCP complex (4.0 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q03164; Q15291; | 100.0 | 1×SAH; 1×ZN; | |||
| Cryo-EM structure of human MLL3-ubNCP complex (4.0 angstrom) |
Heteromer P02281; P06897; P61964; P62799; P62979; P84233; Q15291; Q8NEZ4; | 100.0 | 1×ZN; | |||
| Cryo-EM structure of human MLL1-NCP complex, binding mode1 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 100.0 | 1×SAH; 1×ZN; 1×LYS; 1×GLN; | |||
| Cryo-EM structure of human MLL1-NCP complex, binding mode2 |
Heteromer P02281; P06897; P61964; P62799; P84233; Q03164; Q15291; | 100.0 | 1×SAH; 1×ZN; | |||
| Crystal structure of DPY-30 dimerization/docking domain in complex with Ash2L Sdc1-DPY-30 Interacti… |
Heteromer Q9C005; | 100 | 4×SO4; | |||
| Structure of the SPRY domain of human Ash2L | homo-2-mer | 100.0 | ||||
| Crystal Structure of the N-terminal region of Human Ash2L | monomer | 100 | 1×ZN; | |||
| Crystal structure of Ash2L N-terminal domain | monomer | 100.0 | 1×ZN; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7ud5.1.M | monomer | 0.66 | 100.00 | |||
| 6pwv.1.P | monomer | 0.65 | 100.00 | |||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6e2h.1.C | monomer | 0.67 | 89.18 | |||
| Isoform 2 | 7ud5.1.M | monomer | 0.60 | 100.00 | |||
| Isoform 2 | 6pwv.1.P | monomer | 0.60 | 100.00 | |||
| Isoform 3 | 7ud5.1.M | monomer | 0.66 | 100.00 | |||
| Isoform 3 | 6pwv.1.P | monomer | 0.65 | 100.00 | |||